Laser boost for leishmaniasis treatment?
NCT ID NCT07652021
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether adding a fractional CO₂ laser to standard Glucantime injections helps heal skin sores from leishmaniasis faster and with less scarring. About 150 adults will be randomly assigned to get either the injection alone or the injection plus laser. Researchers will track how quickly sores heal and any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Meglumine antimoniate (Glucantime) injections and fractional CO₂ laser therapy
- What this could lead to
- If it works, this combination could speed up healing and improve scarring for people with cutaneous leishmaniasis.
- What could go wrong
- This is a small, early-phase trial (150 people) that hasn't started yet. The laser may not add benefit or could cause side effects like burns or pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LEISHMINIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Combined military hospital peshawar
Peshawar, Khyber Pukhtunkhwa, 25000, Pakistan